SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC.
$1.83
-0.55%
No data for this timeframe.
Vol
Insider Activity3B / 0S
Insider Net $$964.00
SEC Reports2
Exchange OTC·Sector Miscellaneous Business Credit Institution·Inc. FL·CIK 0001807893·Prev Close $1.84
Recent Activity
May 28, 2026
Insider
Hoechner Carl Christian bought 100 shares
Director @ $2.13 ($213.00)
May 22, 2026
Insider
Hoechner Carl Christian bought 38 shares
Director @ $2.00 ($76.00)
May 21, 2026
Insider
Hoechner Carl Christian bought 300 shares
Director @ $2.25 ($675.00)
Apr 28, 2026
SEC
Standard Premium Finance disclosed a repurchase of 76,000 shares at $2.25 per share under an existing buyback program, t
8-K — Impact 3/10
Apr 20, 2026
SEC
STANDARD PREMIUM FINANCE HOLDINGS, INC. (SPFX) filed a definitive additional proxy statement (DEFA14A) related to a shar
DEFA14A — Impact 3/10
Latest Reports
NEUTRAL
8-K
3/10
Standard Premium Finance disclosed a repurchase of 76,000 shares at $2.25 per share under an existing buyback program, t
Apr 28, 2026
NEUTRAL
DEFA14A
3/10
STANDARD PREMIUM FINANCE HOLDINGS, INC. (SPFX) filed a definitive additional proxy statement (DEFA14A) related to a shar
Apr 20, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | Hoechner Carl | BUY | $213.00 |
| May 22, 2026 | Hoechner Carl | BUY | $76.00 |
| May 21, 2026 | Hoechner Carl | BUY | $675.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 3 transactions. Net insider value: $964.00 ($964.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | Hoechner Carl Christian | Director | BUY | 100 | $2.13 | $213.00 |
| May 22, 2026 | Hoechner Carl Christian | Director | BUY | 38 | $2.00 | $76.00 |
| May 21, 2026 | Hoechner Carl Christian | Director | BUY | 300 | $2.25 | $675.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 3.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2025-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.